Who are the top Indian mycophenolate exporters/manufacturers?

The top Indian mycophenolate exporters in 2025-Q4 include EMCURE PHARMACEUTICALS LTD. 22 Indian companies exported mycophenolate to 28 countries, with total trade value of $3.0M. This report ranks all 22 suppliers by trade value with detailed profiles.

What is the price of Indian mycophenolate exports?

Indian mycophenolate export prices vary by dosage form, destination, and volume. This report provides median prices, price distribution (P5-P95), supplier-level pricing, and a country-by-dosage price matrix — based on 86 real customs shipments.

How to find Indian mycophenolate suppliers/manufacturers?

This free report lists all 22 Indian mycophenolate manufacturers/exporters ranked by trade value, with city, dosage forms, destination countries, and buyer portfolios. Top suppliers get 2-page profiles with trade flow maps.

PHARMA TRADE INTELLIGENCE

INDIA EXPORT INTELLIGENCE REPORT

Mycophenolate

2025-Q4

Comprehensive analysis of India’s mycophenolate export trade — suppliers, buyers, prices, routes, and every shipment record.

86

Shipments

$2.99M

Trade Value

22

Suppliers

20

Buyers

28

Countries

Scan for online report

Talk to our analyst: +91 95950 78788

https://transdatanexus.com/pharmaceutical/mycophenolate

01

PART I — OVERVIEW

Executive Summary

At-a-glance KPIs, key findings, and strategic positioning of India’s mycophenolate trade — 2025-Q4

KEY TAKEAWAY Mycophenolate 2025-Q4 exports total $3.0M across 28 countries, with EMCURE PHARMACEUTICALS LTD commanding 35.7% market share.

TOTAL SHIPMENTS

86

2025-Q4

EXPORT VALUE

$3.0M

FOB USD

TOTAL QUANTITY

5.2M

units shipped

INDIAN SUPPLIERS

22

unique exporters

GLOBAL BUYERS

20

unique importers

DESTINATIONS

28

countries

MEDIAN UNIT PRICE

$2.78

per unit

TOP-5 SHARE

98.9%

of total USD

BRANDED SHARE

59.3%

51 shipments

DOSAGE FORMS

6

product types

6 KEY FINDINGS

1

EMCURE PHARMACEUTICALS LTD is India's #1 Mycophenolate exporter with $1.1M (35.7% market share).→ §5, Indian Supplier Rankings

2

Mycophenolate reached 28 countries, with United Kingdom as the top destination ($953.4K).→ §4, Global Destination Map

3

Market concentration is moderate (HHI: 2464) — top 10 suppliers control 99.8% of exports.→ §5, Indian Supplier Rankings

4

90.0% of buyers (18 of 20) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings

5

Tablet dominates (57.4%) across 6 dosage forms.→ §7, Price Benchmarks

6

28 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities

WHO THIS REPORT IS FOR

S SUPPLIERS (Indian pharma exporters)

See which buyers your competitors are shipping to, at what price, through which ports
Identify buyers that are single-sourced (poaching opportunities)
Benchmark your pricing and catalog vs the Top 25

B BUYERS (global importers)

Discover which Indian exporters supply this product and what they sell
Benchmark the price you are paying vs the market median by country and dosage
Identify alternative suppliers with proven exports to similar destinations

Figure 1.1 EMCURE PHARMACEUTICALS LTD leads in volume — how do 22 exporters compare on price × volume?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Every bubble is one Indian mycophenolate exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.

HOW TO READ THIS REPORT

60 seconds

Scan this page — KPIs, thesis, flagship chart, top findings

5 minutes

Read every Key Takeaway line across §1–§9

30 minutes

Read sections tagged for your role ([S] or [B]) end-to-end

In depth

Drill into §10 for your country · supplier / buyer directories at end

02

PART I — OVERVIEW

About This Report

Data sources, methodology, trust signals, and what this Mycophenolate report covers

KEY TAKEAWAY Every figure in this report is grounded in real commercial mycophenolate trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.

S FOR SUPPLIERS

Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.

B FOR BUYERS

Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian mycophenolate suppliers.

§2.1 Reporting parameters · the scope of this 2025-Q4 Mycophenolate India trade report

P

Product scope

Mycophenolate

All variants merged — branded and generic formulations of mycophenolate

T

Time period

2025-Q4

October, November, December 2025 — a single-quarter snapshot

S

Data sources

Official & public trade records

Government customs filings, public trade databases and licensed commercial feeds

G

Geography

India origin → global

Indian sea and air ports shipping to destination markets worldwide

C

Currency

USD (FOB)

Declared Free-on-Board value at the Indian port of loading

R

Shipments analysed

86

Every commercial mycophenolate trade record in the period, aggregated and deduplicated

§2.2 Our quality process · Figure 2.1

Figure 2.1 From raw trade records to a clean report — the four quality pillars.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.

§2.3 Trust signals · what you can rely on in the numbers you read

DATA COVERAGE

10M+

Pharmaceutical trade records across the full TransData Nexus platform.

COUNTRIES

150+

Origin and destination countries covered in the global pharma trade database.

DATA ACCURACY

99.9%

Validation rate on core fields — supplier, buyer, product, quantity, value.

UPDATE FREQUENCY

Daily

Platform refresh cadence. This report is a snapshot from the same live data.

§2.4 Limitations · what the data does and does not tell you

WHAT THIS DATA DOES AND DOES NOT SAY

Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.

03

PART II — MARKET STRUCTURE

Quarterly Trade Overview

Monthly trends, regional performance, and ranking shifts — 2025-Q4

KEY TAKEAWAY 2025-Q4 followed a mixed: Oct $425.3K, Nov $1.7M, Dec $908.6K. Shipment counts rose across the quarter.

S FOR SUPPLIERS

Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.

B FOR BUYERS

Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.

1

$425.3K

Oct USD

9 shipments

2

$1.7M

Nov USD

+289.7% MoM

3

$908.6K

Dec USD

-45.2% MoM

4

Mixed

Q4 growth shape

Oct → Nov → Dec

Fig 3.1 Nov rose 289.7% in USD but shipment count kept climbing.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $425K, making it the weakest month by value.

Fig 3.2 Q4 cumulative USD reached $3.0M.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.

Fig 3.3 $1.2M rise in Nov, $749K decline in Dec.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.

Fig 3.4 Regional breakdown by month — which corridors swung most?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.

§3.1 Monthly summary

Oct	$425K	9 shipments
Nov	$1.7M	50 shipments
Dec	$909K	27 shipments
Q4 Total	$3.0M	86 shipments

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United Kingdom held #1 throughout the quarter.

Fig 3.6 Top 10 Indian exporters by monthly USD rank.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: EMCURE PHARMACEUTICALS LTD maintained its leading position.

04

PART II — MARKET STRUCTURE

Global Destination Map

Which countries import mycophenolate from India, how much they buy, and who supplies each market

KEY TAKEAWAY United Kingdom absorbs 31.9% of India’s 2025-Q4 mycophenolate trade ($953.4K). Beyond the top 10 destinations, 28 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Europe has 7 destination countries, the widest regional diversity.

S FOR SUPPLIERS

Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 28 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.

B FOR BUYERS

Find your country on the map to see how much mycophenolate India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.

Asia

$251K

8.4% of trade

7 countries · 10 shipments

Europe

$1.2M

40.3% of trade

7 countries · 35 shipments

Americas

$1.2M

41.2% of trade

6 countries · 23 shipments

Africa

$7K

0.2% of trade

6 countries · 10 shipments

Oceania

$292K

9.8% of trade

2 countries · 8 shipments

Fig 4.1 United Kingdom is the #1 corridor ($953K) — 28 flow arcs from India radiate across 5 continents.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: The world map shows every country colored by how much Indian mycophenolate it receives (light = low, dark = high). Orange arcs radiate from India to the top 28 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.

§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers

#	Destination	Total USD	Ships	#1 Indian supplier	USD	#2 Indian supplier	USD	#3 Indian supplier	USD
1	United Kingdom	$953K	11	EMCURE PHARMACEUTICALS LTD	$953K	INTAS PHARMACEUTICALS LTD	$31	—	—
2	Canada	$527K	8	SANDOZ PVT LTD	$481K	EMCURE PHARMACEUTICALS LTD	$46K	—	—
3	United States	$478K	6	ALKEM LABORATORIES LTD	$374K	INTAS PHARMACEUTICALS LTD	$104K	—	—
4	Australia	$277K	7	SANDOZ PVT LTD	$232K	INTAS PHARMACEUTICALS LTD	$45K	SYNERGY TRADING	$561
5	Indonesia	$210K	2	CONCORD BIOTECH LTD	$210K	—	—	—	—
6	Mexico	$159K	5	INTAS PHARMACEUTICALS LTD	$159K	—	—	—	—
7	Netherlands	$106K	4	INTAS PHARMACEUTICALS LTD	$106K	—	—	—	—
8	Peru	$70K	1	EMCURE PHARMACEUTICALS LTD	$70K	—	—	—	—
9	Austria	$54K	1	SANDOZ PVT LTD	$54K	—	—	—	—
10	Greece	$49K	2	INTAS PHARMACEUTICALS LTD	$49K	—	—	—	—

Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.

Fig 4.2 Asia leads at 8.4% of USD — but United Kingdom is the single largest market.

Region → country treemap

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.

§4.2 Destination concentration

31.9%

#1 country share

United Kingdom alone

81.7%

Top 5 share

5 of 28 countries

99.7%

Top 15 share

Long tail of 13 countries = 0.3%

HHI 1771

Destination HHI

Moderately concentrated

28

Countries served

Global pharma reach from India

7

Europe countries

Widest regional diversity

Source: TransData Nexus trade data platform

05

PART III — WHO’S IN THIS MARKET

Indian Supplier Rankings & Profiles

22 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence

KEY TAKEAWAY EMCURE PHARMACEUTICALS LTD ($1.1M, 35.7% share) and SANDOZ PVT LTD ($767.3K) together control 61.4% of India’s 2025-Q4 mycophenolate trade. The top 5 suppliers hold 98.9%. 22 companies shipped at least once.

S FOR SUPPLIERS

Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.

B FOR BUYERS

Find potential Indian mycophenolate suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.

Fig 5.1 EMCURE PHARMACEUTICALS LTD leads by $302K over SANDOZ PVT LTD — top 20 Indian exporters ranked by trade value

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: SYNERGY TRADING is #15 by value but #5 by volume.

Fig 5.2 INTAS PHARMACEUTICALS LTD also leads by shipment count (34) but ranking shifts for volume-heavy players

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: SYNERGY TRADING moves from #5 by volume to #15 by value — fewer but higher-value shipments.

05

PART III — WHO’S IN THIS MARKET

Supply Landscape — Archetypes & Concentration

How India’s 22 mycophenolate suppliers split into strategic segments

KEY TAKEAWAY 6 suppliers (25%) generate 99.4% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.

Fig 5.3 EMCURE PHARMACEUTICALS LTD and SANDOZ PVT LTD sit in the leaders zone — high volume AND high value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.

Fig 5.4 25% of suppliers = 99.4% of USD — classic concentration.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.

Product variety — how many formulations each supplier ships

#	Supplier	Dosage forms	Countries	USD
1	SANDOZ PVT LTD	4	3	$767K
2	INTAS PHARMACEUTICALS LTD	4	11	$538K
3	EMCURE PHARMACEUTICALS LTD	2	3	$1.1M
4	ALKEM LABORATORIES LTD	1	1	$374K
5	CONCORD BIOTECH LTD	1	1	$210K
6	CHOUDHARI IMPEX	1	1	$15K
7	PARKSLEY GLOBAL PVT LTD	1	1	$3K
8	NAMAN PHARMA DRUGS	1	1	$2K
9	MATOSHREE HEALTH CARE PVT LTD	1	1	$2K
10	M T MADON EXPORTS	1	1	$1K

Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.

05

PART III — WHO’S IN THIS MARKET

Supply Landscape — India Origin Geography & Concentration

Which Indian cities and states are the mycophenolate manufacturing hubs

KEY TAKEAWAY Pune and Ahmedabad together account for $1.5M of India’s 2025-Q4 mycophenolate trade.

Fig 5.5 Pune (2 exporters, $1.1M) and Ahmedabad (3 exporters, $380K) are India’s mycophenolate capitals.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.

§5.1 Supplier concentration metrics

98.9%

Top 5 share

5 of 22 suppliers

99.8%

Top 10 share

10 of 22 suppliers

99.4%

Top 25% share

6 suppliers = 99% USD

HHI 2464

Supplier HHI

Moderate

22

Total suppliers

shipped Mycophenolate in 2025-Q4

20+ cities

Indian hubs

Pune and Ahmedabad lead

§5.2 Coming next: 3 exporter deep-dive profiles

Each of the top 3 suppliers gets a dedicated 2-page profile with:

6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
Dosage form breakdown — what formulations they ship
Monthly trend — Oct / Nov / Dec trajectory
Trade flow map — supplier → country → importer connections
Buyer portfolio with lock-in analysis

SUPPLIER PROFILES IN THIS REPORT

#1	EMCURE PHARMACEUTICALS LTD	$1.1M
#2	SANDOZ PVT LTD	$767K
#3	INTAS PHARMACEUTICALS LTD	$538K

#1

EXPORTER PROFILE #1 OF 3

EMCURE PHARMACEUTICALS LTD

Pune · India’s #1 mycophenolate supplier by USD · 2025-Q4

2025-Q4 USD

$1.1M

35.7% market share

SHIPMENTS

12

avg $89K/ship

COUNTRIES

3

destination markets

BUYERS

3

3 single-sourced

BRANDED

42%

of shipments

DOSAGE FORMS

2

product types

TOP 3 DESTINATIONS

United Kingdom is the #1 market at $953K (89% of trade), followed by Peru at $70K. 3 countries served.

#	Country	USD	Ships	Share
1	United Kingdom	$953K	10	89.2%
2	Peru	$70K	1	6.5%
3	Canada	$46K	1	4.3%

MONTHLY TREND

Nov peaked at $588K. Oct was the weakest at $0.

PRODUCT MIX

Tablet dominates at 85% of trade. Capsule (10.8%) and Unknown are secondary formulations.

Tablet

85.0%

Capsule

10.8%

Unknown

4.3%

TOP BUYERS · 3/3 LOCKED IN

3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
TILLOMED LABORATORIES …	United Kingdom	$953K	⚠ Locked
EMCURE PHARMA PERU SOC…	Peru	$70K	⚠ Locked
MARCAN PHARMACEUTICALS…	Canada	$46K	⚠ Locked

#1

EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP

EMCURE PHARMACEUTICALS LTD — Supplier → Country → Importer

3 destination countries, top 5 importers per country

Fig 5.P1.3 United Kingdom absorbs $953K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.

#2

EXPORTER PROFILE #2 OF 3

SANDOZ PVT LTD

Mumbai · India’s #2 mycophenolate supplier by USD · 2025-Q4

2025-Q4 USD

$767K

25.6% market share

SHIPMENTS

11

avg $70K/ship

COUNTRIES

3

destination markets

BUYERS

3

2 single-sourced

BRANDED

64%

of shipments

DOSAGE FORMS

4

product types

TOP 3 DESTINATIONS

Canada is the #1 market at $481K (63% of trade), followed by Australia at $232K. 3 countries served.

#	Country	USD	Ships	Share
1	Canada	$481K	7	62.7%
2	Australia	$232K	3	30.2%
3	Austria	$54K	1	7.1%

MONTHLY TREND

Oct peaked at $366K. Dec was the weakest at $80K.

PRODUCT MIX

Tablet dominates at 59% of trade. Unknown (11.3%) and Capsule are secondary formulations.

Tablet

59.0%

Unknown

11.3%

Capsule

10.8%

Powder

10.5%

Other

8.4%

TOP BUYERS · 2/2 LOCKED IN

2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
SANDOZ CANADA INC	Canada	$481K	⚠ Locked
SANDOZ PTY LTD	Australia	$232K	⚠ Locked
Undisclosed buyer	Austria	$54K	N/A

#2

EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP

SANDOZ PVT LTD — Supplier → Country → Importer

3 destination countries, top 5 importers per country

Fig 5.P2.3 Canada absorbs $481K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.

#3

EXPORTER PROFILE #3 OF 3

INTAS PHARMACEUTICALS LTD

Ahmedabad · India’s #3 mycophenolate supplier by USD · 2025-Q4

2025-Q4 USD

$538K

18.0% market share

SHIPMENTS

34

avg $16K/ship

COUNTRIES

11

destination markets

BUYERS

4

2 single-sourced

BRANDED

59%

of shipments

DOSAGE FORMS

4

product types

TOP 10 DESTINATIONS

Mexico is the #1 market at $159K (29% of trade), followed by Netherlands at $106K. 11 countries served.

#	Country	USD	Ships	Share
1	Mexico	$159K	5	29.5%
2	Netherlands	$106K	4	19.7%
3	United States	$104K	1	19.3%
4	Greece	$49K	2	9.0%
5	Australia	$45K	1	8.3%
6	Hong Kong	$34K	1	6.4%
7	Spain	$21K	11	3.9%
8	Italy	$21K	2	3.9%
9	China	$322	3	0.1%
10	United Kingdom	$31	1	0.0%

MONTHLY TREND

Nov peaked at $403K. Oct was the weakest at $21K.

PRODUCT MIX

Injection dominates at 29% of trade. Unknown (26.1%) and Other are secondary formulations.

Injection

29.5%

Unknown

26.1%

Other

19.3%

Tablet

16.1%

Capsule

9.0%

TOP BUYERS · 2/2 LOCKED IN

2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.

Buyer	Country	USD	Status
Undisclosed buyer	Netherlands	$368K	N/A
Undisclosed buyer	Spain	$149K	N/A
ACCORD HEALTHCARE ITAL…	Italy	$21K	⚠ Locked
STADA HEMOFARM SRL	Romania	$16	⚠ Locked

#3

EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP

INTAS PHARMACEUTICALS LTD — Supplier → Country → Importer

5 destination countries, top 5 importers per country

Fig 5.P3.3 Mexico absorbs $159K — the thickest ribbon.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.

06

PART III — WHO’S IN THIS MARKET

Global Buyer Rankings & Intelligence

20 importers across 28 countries — who is buying Indian mycophenolate and how much

KEY TAKEAWAY The demand side is dramatically more fragmented than supply: the top 18 importers together hold only 69.8% of total USD. 90% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.

S FOR SUPPLIERS

Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).

B FOR BUYERS

See where you rank among global importers of Indian mycophenolate. Compare your USD and shipment count against peers in your country and dosage segment.

Fig 6.1 TILLOMED LABORATORIES LTD is the #1 importer at $953K (31.9%) — top 18 by trade value

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one global importer ranked by USD.

Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Same 18 importers re-ranked by shipment count.

§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?

90%

Single-source

18 buyers rely on exactly 1 Indian supplier

0%

Dual-source

0 buyers use 2 Indian suppliers

0%

Multi-source (3–4)

0 buyers diversified across 3–4

10%

Broad-source (5+)

2 buyers with 5+ Indian suppliers

06

PART III — WHO’S IN THIS MARKET

Single-Source Buyers & Price Benchmark

Lock-in opportunities grouped by country + where each buyer sits on the price spectrum

KEY TAKEAWAY These importers source mycophenolate from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.

S FOR SUPPLIERS

This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.

B FOR BUYERS

If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.

§6.2 Single-source lock-in by country

Canada 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
SANDOZ CANADA INC	SANDOZ PVT LTD	$481K	$3.459	Tablet
MARCAN PHARMACEUTICALS…	EMCURE PHARMACEUTICA…	$46K	$33.467	—

Australia 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
SANDOZ PTY LTD	SANDOZ PVT LTD	$232K	$5.991	Tablet
REPUBLIC OF NAURU, DEP…	SYNERGY TRADING	$373.078	$6.218	Tablet

Italy 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
ACCORD HEALTHCARE ITAL…	INTAS PHARMACEUTICAL…	$21K	$0.066	Tablet
ALLA FATTURA DELLORDIN…	PARKSLEY GLOBAL PVT …	$3K	$40.000	Syrup

Seychelles 2 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
CENTRAL POINT PHARMACY	NALIINI.R.EXPORT PVT…	$867.972	$4.340	Tablet
CAREWELL PHARMACY (PTY…	CHEMSELECT PVT LTD	$409.570	$6.826	Tablet

United Kingdom 1 single-source buyers

Importer	Current supplier	USD	Unit $	Dosage
TILLOMED LABORATORIES …	EMCURE PHARMACEUTICA…	$953K	$5.446	Tablet

§6.3 Price positioning — top 18 importers

#	Importer	Country	USD	$/ship	Tier
1	TILLOMED LABORATORIE…	United Kingdom	$953K	$95K	Premium
2	SANDOZ CANADA INC	Canada	$481K	$69K	Premium
3	ASCEND LABORATORIES …	United States	$271K	$68K	Premium
4	SANDOZ PTY LTD	Australia	$232K	$77K	Premium
5	EMCURE PHARMA PERU S…	Peru	$70K	$70K	Premium
6	MARCAN PHARMACEUTICA…	Canada	$46K	$46K	Premium
7	ACCORD HEALTHCARE IT…	Italy	$21K	$10K	Budget
8	MR VONMUNA	Laos	$7K	$7K	Budget
9	ALLA FATTURA DELLORD…	Italy	$3K	$3K	Budget
10	SALAMA PHARMACUTICAL…	Kenya	$1K	$1K	Budget
11	CENTRAL POINT PHARMACY	Seychelles	$867.972	$868.000	Budget
12	THE PURCHASE MANAGER	Chile	$585.386	$585.000	Budget
13	CAREWELL PHARMACY (P…	Seychelles	$409.570	$205.000	Budget
14	REPUBLIC OF NAURU, D…	Australia	$373.078	$187.000	Budget
15	HEALTH CITY CAYMAN I…	Cayman Islands	$333.366	$167.000	Budget
16	LUSAKA PHARMA CHEM S…	Zambia	$72.880	$73.000	Budget
17	STADA HEMOFARM SRL	Romania	$16.328	$5.000	Budget
18	LLP ROGERS PHARMA	Kazakhstan	$0.200	$0.0000	Budget

06

PART III — WHO’S IN THIS MARKET

Market Relationship Map

The top 20 × 18 supplier ↔ buyer network as a circular flow diagram

Fig 6.3 EMCURE PHARMACEUTICALS LTD → TILLOMED LABORATORIES LTD is the strongest relationship.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left semicircle = top 20 Indian suppliers; right = top 18 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.

07

PART IV — MARKET BEHAVIOR

Price Benchmarks & Analysis

How Indian mycophenolate prices vary by supplier, country and dosage form

KEY TAKEAWAY Mycophenolate prices span 171200× ($0.0013 → $225.23). The coefficient of variation is 3.49. Dosage form, not destination, is the primary price driver.

S FOR SUPPLIERS

Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.

B FOR BUYERS

Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.

§7.1 Price distribution · Table 7.1

Statistic	Value	Interpretation
Min	$0.0013	Lowest observed unit price
P5	$0.063	5th percentile
P25	$0.145	25th percentile (Q1)
Median	$2.78	50th percentile (Q2)
P75	$6.00	75th percentile (Q3)
P95	$15.10	95th percentile
Max	$225.23	Highest observed unit price
Mean	$7.80	Arithmetic average
CV	349%	Coefficient of variation (std/mean)

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

Fig 7.1 NASCENT GLOBAL IMPEX LLP prices at $225.23/unit vs market median $2.78.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).

COMMODITY KINGS

high volume · low unit price

Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. INTAS PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.

BULK LEADERS

high volume · premium price

Branded-generic leaders, above-median pricing. e.g. EMCURE PHARMACEUTICALS LTD Sourcing: hardest to displace; compete on relationship.

LONG-TAIL

low volume · low unit price

Spot/opportunistic players. Sourcing: first to approach for new tenders.

PREMIUM NICHE

low volume · premium price

Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.

07

PART IV — MARKET BEHAVIOR

Price Benchmarks & Analysis

Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage

KEY TAKEAWAY Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.

§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices

↑ TOP 10 HIGHEST USD/UNIT

Date	Exporter	Country	Dosage	Qty	USD	$/unit	Why
Oct 2025	NASCENT GLOBAL I…	United Arab Emirates	Tablet	1	$225.23	$225.23	Specialty / small-batch
Nov 2025	KALINDI OVERSEAS	Chile	Tablet	5	$585.39	$117.08	Specialty / small-batch
Dec 2025	PARKSLEY GLOBAL …	Italy	Syrup	70	$3K	$40.00	Specialty / small-batch
Nov 2025	EMCURE PHARMACEU…	Canada	—	1K	$46K	$33.47	Specialty / small-batch
Dec 2025	CONCORD BIOTECH …	Indonesia	Tablet	8K	$122K	$15.10	Specialty / small-batch
Dec 2025	CONCORD BIOTECH …	Indonesia	Tablet	6K	$87K	$15.10	Specialty / small-batch
Nov 2025	SANDOZ PVT LTD	Austria	—	6K	$54K	$9.10	Specialty / small-batch
Oct 2025	ALKEM LABORATORI…	United States	Tablet	4K	$38K	$8.78	Specialty / small-batch
Nov 2025	ALKEM LABORATORI…	United States	—	12K	$103K	$8.76	Specialty / small-batch
Nov 2025	ALKEM LABORATORI…	United States	—	6K	$51K	$8.72	Specialty / small-batch

↓ TOP 10 LOWEST USD/UNIT

Date	Exporter	Country	Dosage	Qty	USD	$/unit	Why
Dec 2025	INTAS PHARMACEUT…	China	Tablet	85K	$111.24	$0.0013	Bulk generic tablet
Dec 2025	INTAS PHARMACEUT…	China	Tablet	83K	$108.93	$0.0013	Bulk generic tablet
Dec 2025	INTAS PHARMACEUT…	China	Tablet	77K	$101.83	$0.0013	Bulk generic tablet
Nov 2025	INTAS PHARMACEUT…	United States	Other	1.7M	$104K	$0.060	Bulk volume discount
Nov 2025	INTAS PHARMACEUT…	Spain	—	600	$37.55	$0.063	Small sample / trial shipment
Nov 2025	INTAS PHARMACEUT…	Spain	—	280	$17.90	$0.064	Small sample / trial shipment
Dec 2025	INTAS PHARMACEUT…	Italy	Tablet	700	$46.40	$0.066	Small sample / trial shipment
Dec 2025	INTAS PHARMACEUT…	Italy	Tablet	312K	$21K	$0.066
Dec 2025	INTAS PHARMACEUT…	Greece	Capsule	597K	$48K	$0.081
Dec 2025	INTAS PHARMACEUT…	Greece	Capsule	2K	$121.85	$0.081

§7.3 Procurement cheat sheet — median USD/unit by country × dosage

Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.

NEGOTIATION RANGE

Use each cell value as the anchor price. Typical dynamics:

Budget buyer: anchor − 10–15% (floor = cost + freight)
Mid-market: anchor ± 5–10%
Premium/tender: anchor + 10–25% (regulated, quality premium)
Injection/infusion: always 4–10× the tablet price

KEY TAKEAWAYS

Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment

08

PART IV — MARKET BEHAVIOR

Shipping Ports & Trade Routes

Which Indian ports ship mycophenolate, which global ports receive it, and which corridors are high-value vs bulk

KEY TAKEAWAY Mycophenolate leaves India through 8+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), AHMEDABAD AIR, MUNDRA SEA) handle 99.5% of total USD. SEA moves 42% of shipments.

S FOR SUPPLIERS

Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.

B FOR BUYERS

Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.

Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $2.0M — top 8 Indian origin ports by trade value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.

Fig 8.2 Southampton is the #1 global destination port — top 25 by USD value.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.

§8.1 Reference transit times for key India → global corridors

Route	Mode	Transit time	Notes
NHAVA SHEVA SEA (JNPT) → US East Coast	Sea	22–28 days	Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)	Sea	18–24 days	Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK	Air	3–5 days	Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam	Sea	20–26 days	Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow	Air	2–4 days	Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)	Sea	7–12 days	Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)	Road	1–2 days	Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)	Sea	14–20 days	Direct or via Colombo hub

Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.

08

PART IV — MARKET BEHAVIOR

Shipping Ports & Trade Routes

Trade corridors — origin port to mode of transport to destination region

KEY TAKEAWAY SEA dominates at 42% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.

SEA

$2.3M

76.9% of USD · 41.9% of ships

AIR

$692K

23.1% of USD · 58.1% of ships

Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Europe ($953K).

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.

09

PART V — ACTION

Strategic Opportunities & Action Plan

Market concentration, supply-chain risk, and the dependency patterns that signal where to act

KEY TAKEAWAY Spain is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 5041).

S FOR SUPPLIERS

The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.

B FOR BUYERS

The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.

Fig 9.1 Spain (HHI 10,000) is the most concentrated — Kenya (HHI 5,041) is the most competitive.

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.

§9.1 Single-source dependencies

Buyer	Country	Sole supplier	USD	Ships	Risk
TILLOMED LABORATORIE…	United Kingdom	EMCURE PHARMACEU…	$953K	10	CRITICAL
SANDOZ CANADA INC	Canada	SANDOZ PVT LTD	$481K	7	HIGH
ASCEND LABORATORIES …	United States	ALKEM LABORATORI…	$271K	4	HIGH
SANDOZ PTY LTD	Australia	SANDOZ PVT LTD	$232K	3	HIGH
EMCURE PHARMA PERU S…	Peru	EMCURE PHARMACEU…	$70K	1	MEDIUM
MARCAN PHARMACEUTICA…	Canada	EMCURE PHARMACEU…	$46K	1	MEDIUM
ACCORD HEALTHCARE IT…	Italy	INTAS PHARMACEUT…	$21K	2	MEDIUM
MR VONMUNA	Laos	KASO PHARMACEUTI…	$7K	1	MEDIUM

Conclusion: 18 buyers depend on exactly one Indian supplier, representing $2.1M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.

§9.2 Multi-source resilience

Buyer	Country	Suppliers	USD	Dominant	Resilience

Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.

09

PART V — ACTION

Strategic Opportunities & Action Plan

Market entry playbook and risk landscape by destination country

KEY TAKEAWAY 15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).

§9.3 Sourcing recommendations · Table 9.1

Country	Tier	Lead	Price	Risk	Entry approach
United Kingdom	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Canada	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
United States	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Australia	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Indonesia	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Mexico	Tier 3 (emerging)	14–28 days (sea)	$0.10–$1/unit	LOW	First-mover advantage
Netherlands	Tier 3 (emerging)	14–28 days (sea)	$0.10–$1/unit	LOW	First-mover advantage
Peru	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Austria	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Greece	Tier 3 (emerging)	3–5 days (air)	$0.01–$0.10/unit	LOW	First-mover advantage
Hong Kong	Tier 3 (emerging)	3–5 days (air)	$0.10–$1/unit	LOW	First-mover advantage
Italy	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage
Spain	Tier 3 (emerging)	3–5 days (air)	$0.10–$1/unit	LOW	First-mover advantage
Papua New Guinea	Tier 3 (emerging)	14–28 days (sea)	$0.10–$1/unit	LOW	First-mover advantage
Laos	Tier 3 (emerging)	3–5 days (air)	$1–$10/unit	LOW	First-mover advantage

For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.

Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).

Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources

How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.

09

PART V — ACTION

Action Plan & Easy-Entry Markets

12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers

KEY TAKEAWAY Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.

S

FOR SUPPLIERS

ID	Action	Timing	Impact
A1	Pitch top single-source buyer in United Kingdom	This Q	HIGH
A2	Offer alternative to top multi-source buyer	This Q	HIGH
A3	Audit Spain lock-ins (HHI 10000)	This Q	MED
A5	Enter United Kingdom (2 suppliers)	This Q	HIGH
A6	Enter Canada (2 suppliers)	This Q	MED
A8	Build Canada distribution	6–12m	HIGH
A9	Bundle injection/infusion catalog for premium markets	6–12m	MED

B

FOR BUYERS

ID	Action	Timing	Impact
A4	Monitor rising exporters (climbers)	This Q	MED
A7	Register for United Kingdom tenders	6–12m	HIGH
A10	Track quarterly HHI shifts across key destinations	This Q	LOW
A11	Map competitor buyer portfolios quarterly	This Q	MED
A12	Qualify second source for single-source buyers	This Q	MED

§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers

#	Country	Region	Suppliers	Q4 USD	Growth	Barrier	Why this is easy
1	United Kingdom	Other	2	$953K	0%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
2	Canada	Other	2	$527K	-100%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
3	United States	Other	2	$478K	-100%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
4	Australia	Other	3	$277K	+4.5%	LOW	Low competition (3 suppliers), accessible market
5	Indonesia	Asia	1	$210K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
6	Mexico	Other	1	$159K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
7	Netherlands	Other	1	$106K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
8	Peru	Other	1	$70K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
9	Austria	Other	1	$54K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
10	Greece	Other	1	$49K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
11	Hong Kong	Asia	1	$34K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
12	Italy	Other	2	$24K	0%	LOW	Only 2 Indian suppliers — near-monopoly, easy second-source entry
13	Spain	Other	1	$21K	-100%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
14	Papua New Guinea	Other	1	$15K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry
15	Laos	Asia	1	$7K	0%	LOW	Only 1 Indian suppliers — near-monopoly, easy second-source entry

This report covers 86 2025-Q4 Mycophenolate shipments. TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020. → transdatanexus.com/pharmaceutical/mycophenolate

10

PART VI — EVIDENCE REGISTER

Comprehensive Shipment Records by Region

Authoritative source behind all analytics in this report — every shipment appears exactly once

KEY TAKEAWAY This section contains every one of the 86 2025-Q4 mycophenolate shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.

S FOR SUPPLIERS

Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.

B FOR BUYERS

Jump to your country to see every Indian mycophenolate shipment that arrived in 2025-Q4: supplier, price, dosage, port.

§10.1 Global totals

SHIPMENTS

86

across all regions

TOTAL USD

$2.99M

2025-Q4 FOB value

UNITS

5.2M

tablets, capsules, etc.

SUPPLIERS

22

Indian exporters

BUYERS

20

global importers

COUNTRIES

28

destinations

§10.2 Regional breakdown

Africa

$7K

0.2%

6 ctry · 10 ships

Asia

$251K

8.4%

7 ctry · 10 ships

Europe

$1.21M

40.3%

7 ctry · 35 ships

Americas

$1.23M

41.2%

6 ctry · 23 ships

Oceania

$292K

9.8%

2 ctry · 8 ships

§10.3 Key insights from the data

🌍

Africa is the largest region at $7K (0.2%), spanning 6 countries.

🏢

22 Indian suppliers shipped to 20 buyers across 28 countries — average shipment value $35K.

📄

Top 0 markets: .

🔍

Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.

§10.4 How to read a country page

1

6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.

2

4 mini-lists — top exporters, importers, dosages, monthly trend.

3

Shipment register — every row grouped by exporter. No row is duplicated or omitted.

10

PART VI — DRILL-DOWN · AFRICA

Region: Africa

6 countries · 10 shipments · $7K · 8 Indian suppliers · 6 buyers

SHIPMENTS

10

USD

$7K

COUNTRIES

6

SUPPLIERS

8

BUYERS

6

HHI

1,860

moderate

Top 6 destination countries in Africa

1

Kenya (42.8%)

$3K

2

Ethiopia (22.7%)

$2K

3

Seychelles (18.1%)

$1K

4

Madagascar (15.2%)

$1K

5

Zambia (1.0%)

$72.88

6

Burkina Faso (0.0%)

$3.47

Top 8 Indian suppliers into Africa

1

NAMAN PHARMA DRUGS

$2K

2

MATOSHREE HEALTH CARE PVT LTD

$2K

3

M T MADON EXPORTS

$1K

4

FLORENCIA HEALTHCARE PVT LTD

$1K

5

NALIINI.R.EXPORT PVT LTD

$867.97

6

CHEMSELECT PVT LTD

$409.57

7

MEDICOS LIFESCIENCES

$72.88

8

SANSKRUTI PHARMA

$3.47

Top 4 Africa importers

1

SALAMA PHARMACUTICALS LTD · Kenya

$1K

2

CENTRAL POINT PHARMACY · Seychelles

$867.97

3

CAREWELL PHARMACY (PTY)LTD · Seychelles

$409.57

4

LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia

$72.88

Top 2 dosage forms

1

Tablet

$7K

2

Capsule

$3.47

Monthly trend

Month	Ships	USD	Avg/ship
Oct	1	$867.97	$867.97
Nov	3	$482.45	$160.82
Dec	6	$6K	$948.60

Shipment register · 10 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — NAMAN PHARMA DRUGS · 2 shipments · $2K
1	Dec 2025	UNKNOWN BUYER	Kenya	Tablet	300	NOS	$4.26	$1K	MUMBAI AIR (SAHAR)	NAIROBI	AIR
2	Dec 2025	UNKNOWN BUYER	Kenya	Tablet	60	NOS	$6.09	$365.24	MUMBAI AIR (SAHAR)	NAIROBI	AIR
SUPPLIER #2 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $2K
3	Dec 2025	UNKNOWN BUYER	Ethiopia	Tablet	1.3K	NOS	$1.21	$2K	MUMBAI AIR (SAHAR)	ADDIS ABABA	AIR
SUPPLIER #3 — M T MADON EXPORTS · 1 shipments · $1K
4	Dec 2025	SALAMA PHARMACUTICALS LTD	Kenya	Tablet	600	NOS	$2.29	$1K	MUMBAI AIR (SAHAR)	NAIROBI	AIR
SUPPLIER #4 — FLORENCIA HEALTHCARE PVT LTD · 1 shipments · $1K
5	Dec 2025	UNLISTED BUYER	Madagascar	Tablet	300	NOS	$3.57	$1K	DELHI AIR	ANTANANARIVO	AIR
SUPPLIER #5 — NALIINI.R.EXPORT PVT LTD · 1 shipments · $867.97
6	Oct 2025	CENTRAL POINT PHARMACY	Seychelles	Tablet	200	NOS	$4.34	$867.97	CHENNAI AIR	MAHE ISLAND	AIR
SUPPLIER #6 — CHEMSELECT PVT LTD · 2 shipments · $409.57
7	Nov 2025	CAREWELL PHARMACY (PTY)LTD	Seychelles	Tablet	30	NOS	$6.83	$204.79	COCHIN AIR	MAHE ISLAND	AIR
8	Nov 2025	CAREWELL PHARMACY (PTY)LTD	Seychelles	Tablet	30	NOS	$6.83	$204.79	COCHIN AIR	MAHE ISLAND	AIR
SUPPLIER #7 — MEDICOS LIFESCIENCES · 1 shipments · $72.88
9	Nov 2025	LUSAKA PHARMA CHEM SUPPLIES LTD	Zambia	Tablet	54	NOS	$1.35	$72.88	AHMEDABAD AIR	LUSAKA	AIR
SUPPLIER #8 — SANSKRUTI PHARMA · 1 shipments · $3.47
10	Dec 2025	UNLISTED BUYER	Burkina Faso	Capsule	3	NOS	$1.16	$3.47	MUMBAI AIR (SAHAR)	OUAGADOUGOU	AIR

10

PART VI — DRILL-DOWN · ASIA

Region: Asia

7 countries · 10 shipments · $251K · 6 Indian suppliers · 4 buyers

SHIPMENTS

10

USD

$251K

COUNTRIES

7

SUPPLIERS

6

BUYERS

4

HHI

7,142

concentrated

Top 7 destination countries in Asia

1

Indonesia (83.3%)

$210K

2

Hong Kong (13.7%)

$34K

3

Laos (2.7%)

$7K

4

China (0.1%)

$322.00

5

United Arab Emirates (0.1%)

$225.23

6

Iraq (0.0%)

$113.76

7

Kazakhstan (0.0%)

$0.200

Top 6 Indian suppliers into Asia

1

CONCORD BIOTECH LTD

$210K

2

INTAS PHARMACEUTICALS LTD

$35K

3

KASO PHARMACEUTICALS

$7K

4

NASCENT GLOBAL IMPEX LLP

$225.23

5

VATS INDUSTRIES PVT LTD

$113.76

6

PANACEA BIOTEC PHARMA LTD

$0.200

Top 2 Asia importers

1

MR VONMUNA · Laos

$7K

2

LLP ROGERS PHARMA · Kazakhstan

$0.200

Top 2 dosage forms

1

Tablet

$210K

2

Unknown

$41K

Monthly trend

Month	Ships	USD	Avg/ship
Oct	1	$225.23	$225.23
Nov	4	$41K	$10K
Dec	5	$210K	$42K

Shipment register · 10 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — CONCORD BIOTECH LTD · 2 shipments · $210K
1	Dec 2025	UNLISTED BUYER	Indonesia	Tablet	8.1K	NOS	$15.10	$122K	AHMEDABAD AIR	JAKARTA SOEKARNO-HA	AIR
2	Dec 2025	UNLISTED BUYER	Indonesia	Tablet	5.8K	NOS	$15.10	$87K	AHMEDABAD AIR	JAKARTA SOEKARNO-HA	AIR
SUPPLIER #2 — INTAS PHARMACEUTICALS LTD · 4 shipments · $35K
3	Nov 2025	UNLISTED BUYER	Hong Kong		218.4K	TBS	$0.158	$34K	AHMEDABAD AIR	HONG KONG	AIR
4	Dec 2025	UNLISTED BUYER	China	Tablet	84.5K	TBS	$0.0013	$111.24	MUMBAI AIR (SAHAR)	CHONGQING	AIR
5	Dec 2025	UNLISTED BUYER	China	Tablet	77.4K	TBS	$0.0013	$101.83	MUMBAI AIR (SAHAR)	CHONGQING	AIR
6	Dec 2025	UNLISTED BUYER	China	Tablet	82.8K	TBS	$0.0013	$108.93	MUMBAI AIR (SAHAR)	CHONGQING	AIR
SUPPLIER #3 — KASO PHARMACEUTICALS · 1 shipments · $7K
7	Nov 2025	MR VONMUNA	Laos		1.3K	NOS	$5.44	$7K	DELHI AIR	VIENTIANE	AIR
SUPPLIER #4 — NASCENT GLOBAL IMPEX LLP · 1 shipments · $225.23
8	Oct 2025	UNLISTED BUYER	United Arab Emirates	Tablet	1	NOS	$225.23	$225.23	NHAVA SHEVA SEA (JNPT)	Sharjah	SEA
SUPPLIER #5 — VATS INDUSTRIES PVT LTD · 1 shipments · $113.76
9	Nov 2025	UNKNOWN BUYER	Iraq		400	NOS	$0.284	$113.76	DELHI AIR	BAGDAD, METROPOLITAN	AIR
SUPPLIER #6 — PANACEA BIOTEC PHARMA LTD · 1 shipments · $0.200
10	Nov 2025	LLP ROGERS PHARMA	Kazakhstan		1	NOS	$0.200	$0.200	DELHI AIR	ALMATY	AIR

10

PART VI — DRILL-DOWN · EUROPE

Region: Europe

7 countries · 35 shipments · $1.21M · 4 Indian suppliers · 6 buyers

SHIPMENTS

35

USD

$1.21M

COUNTRIES

7

SUPPLIERS

4

BUYERS

6

HHI

6,525

concentrated

Top 7 destination countries in Europe

1

United Kingdom (79.0%)

$953K

2

Netherlands (8.8%)

$106K

3

Austria (4.5%)

$54K

4

Greece (4.0%)

$49K

5

Italy (2.0%)

$24K

6

Spain (1.7%)

$21K

7

Romania (0.0%)

$16.33

Top 4 Indian suppliers into Europe

1

EMCURE PHARMACEUTICALS LTD

$953K

2

INTAS PHARMACEUTICALS LTD

$196K

3

SANDOZ PVT LTD

$54K

4

PARKSLEY GLOBAL PVT LTD

$3K

Top 4 Europe importers

1

TILLOMED LABORATORIES LTD · United Kingdom

$953K

2

ACCORD HEALTHCARE ITALIA SRL · Italy

$21K

3

ALLA FATTURA DELLORDINE EMESSA ALL · Italy

$3K

4

STADA HEMOFARM SRL · Romania

$16.33

Top 4 dosage forms

1

Tablet

$880K

2

Capsule

$164K

3

Unknown

$161K

4

Syrup

$3K

Monthly trend

Month	Ships	USD	Avg/ship
Oct	2	$21K	$10K
Nov	20	$633K	$32K
Dec	13	$553K	$43K

Shipment register · 35 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — EMCURE PHARMACEUTICALS LTD · 10 shipments · $953K
1	Nov 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.4K	NOS	$6.02	$105K	NHAVA SHEVA SEA (JNPT)	Southampton	SEA
2	Nov 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.4K	NOS	$5.94	$103K	NHAVA SHEVA SEA (JNPT)	Southampton	SEA
3	Nov 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.5K	NOS	$4.99	$88K	NHAVA SHEVA SEA (JNPT)	Southampton	SEA
4	Nov 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.7K	NOS	$4.99	$88K	NHAVA SHEVA SEA (JNPT)	Southampton	SEA
5	Nov 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.7K	NOS	$4.99	$89K	NHAVA SHEVA SEA (JNPT)	Southampton	SEA
6	Dec 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.7K	NOS	$5.20	$92K	NHAVA SHEVA SEA (JNPT)	Felixstowe	SEA
7	Dec 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.5K	NOS	$5.20	$91K	NHAVA SHEVA SEA (JNPT)	Felixstowe	SEA
8	Dec 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.3K	NOS	$5.20	$90K	NHAVA SHEVA SEA (JNPT)	Felixstowe	SEA
9	Dec 2025	TILLOMED LABORATORIES LTD	United Kingdom	Tablet	17.6K	NOS	$5.25	$93K	NHAVA SHEVA SEA (JNPT)	Southampton	SEA
10	Dec 2025	TILLOMED LABORATORIES LTD	United Kingdom	Capsule	17.2K	NOS	$6.70	$115K	NHAVA SHEVA SEA (JNPT)	Southampton	SEA
SUPPLIER #2 — INTAS PHARMACEUTICALS LTD · 23 shipments · $196K
11	Oct 2025	UNLISTED BUYER	Spain	Tablet	94.6K	TBS	$0.217	$21K	AHMEDABAD AIR	BARCELONA	AIR
12	Oct 2025	UNLISTED BUYER	Spain	Tablet	600	TBS	$0.217	$130.40	AHMEDABAD AIR	BARCELONA	AIR
13	Nov 2025	UNLISTED BUYER	Spain		280	NOS	$0.064	$17.90	AHMEDABAD AIR	BARCELONA	AIR
14	Nov 2025	UNLISTED BUYER	Spain		300	TBS	$0.104	$31.18	AHMEDABAD AIR	BARCELONA	AIR
15	Nov 2025	UNLISTED BUYER	Spain		600	NOS	$0.063	$37.55	AHMEDABAD AIR	BARCELONA	AIR
16	Nov 2025	UNLISTED BUYER	Spain		450	TBS	$0.102	$45.82	AHMEDABAD AIR	BARCELONA	AIR
17	Nov 2025	UNLISTED BUYER	Spain		450	TBS	$0.102	$45.73	AHMEDABAD AIR	BARCELONA	AIR
18	Nov 2025	UNLISTED BUYER	Spain		450	TBS	$0.101	$45.58	AHMEDABAD AIR	BARCELONA	AIR
19	Nov 2025	UNLISTED BUYER	Spain		450	TBS	$0.102	$45.73	AHMEDABAD AIR	BARCELONA	AIR
20	Nov 2025	UNLISTED BUYER	Spain		500	TBS	$0.109	$54.72	AHMEDABAD AIR	BARCELONA	AIR
21	Nov 2025	UNLISTED BUYER	Spain		500	TBS	$0.109	$54.72	AHMEDABAD AIR	BARCELONA	AIR
22	Nov 2025	UNKNOWN BUYER	Netherlands		627.0K	TBS	$0.134	$84K	MUNDRA SEA	Rotterdam	SEA
23	Nov 2025	UNKNOWN BUYER	Netherlands		1.1K	TBS	$0.134	$141.13	MUNDRA SEA	Rotterdam	SEA
24	Nov 2025	UNKNOWN BUYER	Netherlands		145.8K	TBS	$0.145	$21K	MUNDRA SEA	Rotterdam	SEA
25	Nov 2025	UNKNOWN BUYER	Netherlands		1.3K	TBS	$0.145	$181.58	MUNDRA SEA	Rotterdam	SEA
26	Nov 2025	UNLISTED BUYER	United Kingdom	Tablet	300	TBS	$0.104	$31.08	AHMEDABAD AIR	LONDON - HEATHROW	AIR
27	Dec 2025	UNLISTED BUYER	Greece	Capsule	596.7K	NOS	$0.081	$48K	AHMEDABAD AIR	ATHENS	AIR
28	Dec 2025	UNLISTED BUYER	Greece	Capsule	1.5K	NOS	$0.081	$121.85	AHMEDABAD AIR	ATHENS	AIR
29	Dec 2025	ACCORD HEALTHCARE ITALIA SRL	Italy	Tablet	312.2K	TBS	$0.066	$21K	AHMEDABAD AIR	MILAN	AIR
30	Dec 2025	ACCORD HEALTHCARE ITALIA SRL	Italy	Tablet	700	TBS	$0.066	$46.40	AHMEDABAD AIR	MILAN	AIR
31	Dec 2025	STADA HEMOFARM SRL	Romania	Tablet	6	NOS	$0.710	$4.26	AHMEDABAD AIR	BUCHAREST, OTOPENI	AIR
32	Dec 2025	STADA HEMOFARM SRL	Romania	Tablet	11	NOS	$0.710	$7.81	AHMEDABAD AIR	BUCHAREST, OTOPENI	AIR
33	Dec 2025	STADA HEMOFARM SRL	Romania	Tablet	6	NOS	$0.710	$4.26	AHMEDABAD AIR	BUCHAREST, OTOPENI	AIR
SUPPLIER #3 — SANDOZ PVT LTD · 1 shipments · $54K
34	Nov 2025	UNKNOWN BUYER	Austria		6.0K	PCS	$9.10	$54K	MUMBAI AIR (SAHAR)	VIENNA	AIR
SUPPLIER #4 — PARKSLEY GLOBAL PVT LTD · 1 shipments · $3K
35	Dec 2025	ALLA FATTURA DELLORDINE EMESSA ALL	Italy	Syrup	70	NOS	$40.00	$3K	MUMBAI AIR (SAHAR)	MILAN - MALPENSA	AIR

10

PART VI — DRILL-DOWN · AMERICAS

Region: Americas

6 countries · 23 shipments · $1.23M · 6 Indian suppliers · 7 buyers

SHIPMENTS

23

USD

$1.23M

COUNTRIES

6

SUPPLIERS

6

BUYERS

7

HHI

2,978

concentrated

Top 6 destination countries in Americas

1

Canada (42.7%)

$527K

2

United States (38.7%)

$478K

3

Mexico (12.9%)

$159K

4

Peru (5.7%)

$70K

5

Chile (0.0%)

$585.39

6

Cayman Islands (0.0%)

$333.37

Top 6 Indian suppliers into Americas

1

SANDOZ PVT LTD

$481K

2

ALKEM LABORATORIES LTD

$374K

3

INTAS PHARMACEUTICALS LTD

$262K

4

EMCURE PHARMACEUTICALS LTD

$116K

5

KALINDI OVERSEAS

$585.39

6

NARAYANA HRUDAYALAYA LTD

$333.37

Top 6 Americas importers

1

SANDOZ CANADA INC · Canada

$481K

2

ASCEND LABORATORIES LLC · United States

$271K

3

EMCURE PHARMA PERU SOCIEDAD · Peru

$70K

4

MARCAN PHARMACEUTICALS INC · Canada

$46K

5

THE PURCHASE MANAGER · Chile

$585.39

6

HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands

$333.37

Top 5 dosage forms

1

Tablet

$442K

2

Unknown

$382K

3

Other

$169K

4

Injection

$159K

5

Capsule

$83K

Monthly trend

Month	Ships	USD	Avg/ship
Oct	4	$284K	$71K
Nov	19	$950K	$50K
Dec	0	$0.0000	—

Shipment register · 23 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — SANDOZ PVT LTD · 7 shipments · $481K
1	Oct 2025	SANDOZ CANADA INC	Canada	Tablet	25.0K	PCS	$3.27	$82K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
2	Oct 2025	SANDOZ CANADA INC	Canada	Capsule	25.3K	PCS	$3.27	$83K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
3	Oct 2025	SANDOZ CANADA INC	Canada	Tablet	24.9K	PCS	$3.27	$82K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
4	Nov 2025	SANDOZ CANADA INC	Canada	Other	13.4K	PCS	$4.84	$65K	MUMBAI AIR (SAHAR)	Toronto	AIR
5	Nov 2025	SANDOZ CANADA INC	Canada	Tablet	12.4K	PCS	$3.28	$41K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
6	Nov 2025	SANDOZ CANADA INC	Canada	Tablet	25.5K	PCS	$3.30	$84K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
7	Nov 2025	SANDOZ CANADA INC	Canada	Tablet	12.5K	PCS	$3.62	$45K	NHAVA SHEVA SEA (JNPT)	Montreal	SEA
SUPPLIER #2 — ALKEM LABORATORIES LTD · 5 shipments · $374K
8	Oct 2025	ASCEND LABORATORIES LLC	United States	Tablet	4.3K	NOS	$8.78	$38K	NHAVA SHEVA SEA (JNPT)	Fairdale	SEA
9	Nov 2025	ASCEND LABORATORIES LLC	United States		5.9K	NOS	$8.72	$51K	NHAVA SHEVA SEA (JNPT)	Newark	SEA
10	Nov 2025	ASCEND LABORATORIES LLC	United States		11.8K	NOS	$8.64	$102K	NHAVA SHEVA SEA (JNPT)	Newark	SEA
11	Nov 2025	ASCEND LABORATORIES LLC	United States		13.7K	NOS	$5.79	$79K	NHAVA SHEVA SEA (JNPT)	Newark	SEA
12	Nov 2025	UNKNOWN BUYER	United States		11.8K	NOS	$8.76	$103K	NHAVA SHEVA SEA (JNPT)	Newark	SEA
SUPPLIER #3 — INTAS PHARMACEUTICALS LTD · 6 shipments · $262K
13	Nov 2025	UNKNOWN BUYER	Mexico	Injection	89.9K	NOS	$0.343	$31K	MUNDRA SEA	Veracruz	SEA
14	Nov 2025	UNKNOWN BUYER	Mexico	Injection	91.9K	NOS	$0.347	$32K	MUNDRA SEA	Veracruz	SEA
15	Nov 2025	UNKNOWN BUYER	Mexico	Injection	91.6K	NOS	$0.347	$32K	MUNDRA SEA	Veracruz	SEA
16	Nov 2025	UNKNOWN BUYER	Mexico	Injection	92.2K	NOS	$0.347	$32K	MUNDRA SEA	Veracruz	SEA
17	Nov 2025	UNKNOWN BUYER	Mexico	Injection	92.5K	NOS	$0.347	$32K	MUNDRA SEA	Veracruz	SEA
18	Nov 2025	UNKNOWN BUYER	United States	Other	1.7M	NOS	$0.060	$104K	AHMEDABAD AIR	CHICAGO O'HARE INT'L	AIR
SUPPLIER #4 — EMCURE PHARMACEUTICALS LTD · 2 shipments · $116K
19	Nov 2025	EMCURE PHARMA PERU SOCIEDAD	Peru	Tablet	10.0K	NOS	$6.99	$70K	DELHI AIR	LIMA -	AIR
20	Nov 2025	MARCAN PHARMACEUTICALS INC	Canada		1.4K	NOS	$33.47	$46K	MUMBAI AIR (SAHAR)	Toronto	AIR
SUPPLIER #5 — KALINDI OVERSEAS · 1 shipments · $585.39
21	Nov 2025	THE PURCHASE MANAGER	Chile	Tablet	5	NOS	$117.08	$585.39	MUMBAI AIR (SAHAR)	SANTIAGO DE CHILE -	AIR
SUPPLIER #6 — NARAYANA HRUDAYALAYA LTD · 2 shipments · $333.37
22	Nov 2025	HEALTH CITY CAYMAN ISLANDS (HCCI)	Cayman Islands	Tablet	300	NOS	$0.555	$166.64	MUMBAI AIR (SAHAR)	GRAND CAYMAN	AIR
23	Nov 2025	HEALTH CITY CAYMAN ISLANDS (HCCI)	Cayman Islands	Tablet	300	NOS	$0.556	$166.73	MUMBAI AIR (SAHAR)	GRAND CAYMAN	AIR

10

PART VI — DRILL-DOWN · OCEANIA

Region: Oceania

2 countries · 8 shipments · $292K · 4 Indian suppliers · 4 buyers

SHIPMENTS

8

USD

$292K

COUNTRIES

2

SUPPLIERS

4

BUYERS

4

HHI

6,564

concentrated

Top 2 destination countries in Oceania

1

Australia (94.9%)

$277K

2

Papua New Guinea (5.1%)

$15K

Top 4 Indian suppliers into Oceania

1

SANDOZ PVT LTD

$232K

2

INTAS PHARMACEUTICALS LTD

$45K

3

CHOUDHARI IMPEX

$15K

4

SYNERGY TRADING

$560.78

Top 2 Oceania importers

1

SANDOZ PTY LTD · Australia

$232K

2

REPUBLIC OF NAURU, DEPARTMENT OF · Australia

$373.08

Top 3 dosage forms

1

Tablet

$180K

2

Powder

$80K

3

Unknown

$32K

Monthly trend

Month	Ships	USD	Avg/ship
Oct	1	$120K	$120K
Nov	4	$33K	$8K
Dec	3	$140K	$47K

Shipment register · 8 rows · grouped by exporter

#	Date	Importer	Country	Dosage	Qty	Unit	Unit $	Total $	Origin	Dest	Mode
SUPPLIER #1 — SANDOZ PVT LTD · 3 shipments · $232K
1	Oct 2025	SANDOZ PTY LTD	Australia	Tablet	20.3K	PCS	$5.88	$120K	NHAVA SHEVA SEA (JNPT)	Sydney	SEA
2	Nov 2025	SANDOZ PTY LTD	Australia		5.1K	PCS	$6.37	$32K	NHAVA SHEVA SEA (JNPT)	Sydney	SEA
3	Dec 2025	SANDOZ PTY LTD	Australia	Powder	13.3K	PCS	$6.02	$80K	NHAVA SHEVA SEA (JNPT)	Sydney	SEA
SUPPLIER #2 — INTAS PHARMACEUTICALS LTD · 1 shipments · $45K
4	Dec 2025	UNLISTED BUYER	Australia	Tablet	324.0K	TBS	$0.138	$45K	MUNDRA SEA	Sydney	SEA
SUPPLIER #3 — CHOUDHARI IMPEX · 1 shipments · $15K
5	Dec 2025	UNLISTED BUYER	Papua New Guinea	Tablet	46.0K	NOS	$0.325	$15K	CHENNAI SEA	Port Moresby	SEA
SUPPLIER #4 — SYNERGY TRADING · 3 shipments · $560.78
6	Nov 2025	REPUBLIC OF NAURU, DEPARTMENT OF	Australia	Tablet	30	NOS	$6.18	$185.37	MUMBAI AIR (SAHAR)	BRISBANE	AIR
7	Nov 2025	REPUBLIC OF NAURU, DEPARTMENT OF	Australia	Tablet	30	NOS	$6.26	$187.71	MUMBAI AIR (SAHAR)	BRISBANE	AIR
8	Nov 2025	UNKNOWN BUYER	Australia	Tablet	30	NOS	$6.26	$187.71	MUMBAI AIR (SAHAR)	BRISBANE	AIR

10

PART VI — EVIDENCE REGISTER

Indian Supplier Directory

All 22 Indian mycophenolate exporters — complete list ranked by USD

KEY TAKEAWAY This directory lists every Indian company that shipped mycophenolate in 2025-Q4.

S FOR SUPPLIERS

Find yourself and your competitors. Compare shipment count, USD, and destination regions.

B FOR BUYERS

Search for potential Indian suppliers. Filter by dosage form and destination region.

#	Supplier	City	Ships	USD	Dosage forms	Primary regions
1	EMCURE PHARMACEUTICALS LTD	PUNE	12	$1.07M	Tablet, Capsule	Europe, Americas
2	SANDOZ PVT LTD	MUMBAI	11	$767K	Tablet, Capsule, Other	Oceania, Americas
3	INTAS PHARMACEUTICALS LTD	AHMEDABAD	34	$538K	Tablet, Injection, Other	Europe, Americas
4	ALKEM LABORATORIES LTD	LOWER PAREL	5	$374K	Tablet	Americas
5	CONCORD BIOTECH LTD	AHMEDABAD	2	$210K	Tablet	Asia
6	CHOUDHARI IMPEX	CHENNAI	1	$15K	Tablet	Oceania
7	KASO PHARMACEUTICALS	NEW DELHI	1	$7K		Asia
8	PARKSLEY GLOBAL PVT LTD	Pune	1	$3K	Syrup	Europe
9	NAMAN PHARMA DRUGS	MUMBAI	2	$2K	Tablet	Africa
10	MATOSHREE HEALTH CARE PVT LTD	THAKURDWAR MUMBAI	1	$2K	Tablet	Africa
11	M T MADON EXPORTS	MUMBAI	1	$1K	Tablet	Africa
12	FLORENCIA HEALTHCARE PVT LTD	NOIDA	1	$1K	Tablet	Africa
13	NALIINI.R.EXPORT PVT LTD	CHENNAI	1	$867.97	Tablet	Africa
14	KALINDI OVERSEAS	MUMBAI	1	$585.39	Tablet	Americas
15	SYNERGY TRADING	VADODARA/GUJARAT	3	$560.78	Tablet	Oceania
16	CHEMSELECT PVT LTD	THIRUVANANTHAPURAM	2	$409.57	Tablet	Africa
17	NARAYANA HRUDAYALAYA LTD	BANGALORE	2	$333.37	Tablet	Americas
18	NASCENT GLOBAL IMPEX LLP	ANDHERI WEST MUMBAI	1	$225.23	Tablet	Asia
19	VATS INDUSTRIES PVT LTD	DDA SHED	1	$113.76		Asia
20	MEDICOS LIFESCIENCES	AHMEDABAD	1	$72.88	Tablet	Africa
21	SANSKRUTI PHARMA	SURAT	1	$3.47	Capsule	Africa
22	PANACEA BIOTEC PHARMA LTD	NEW DELHI	1	$0.200		Asia

10

PART VI — EVIDENCE REGISTER

Global Buyer Directory

All 18 global mycophenolate importers — complete list ranked by USD

KEY TAKEAWAY This directory lists every company that imported Indian mycophenolate in 2025-Q4.

S FOR SUPPLIERS

Search for potential customers by country and dosage form.

B FOR BUYERS

Find your company and see which Indian supplier serves you.

#	Buyer	Country	Ships	USD	Primary supplier	Dosage forms
1	TILLOMED LABORATORIES LTD	United Kingdom	10	$953K	EMCURE PHARMACEUTICA…	Tablet, Capsule
2	SANDOZ CANADA INC	Canada	7	$481K	SANDOZ PVT LTD	Tablet, Capsule, Other
3	ASCEND LABORATORIES LLC	United States	4	$271K	ALKEM LABORATORIES LTD	Tablet
4	SANDOZ PTY LTD	Australia	3	$232K	SANDOZ PVT LTD	Tablet, Powder
5	EMCURE PHARMA PERU SOCIEDAD	Peru	1	$70K	EMCURE PHARMACEUTICA…	Tablet
6	MARCAN PHARMACEUTICALS INC	Canada	1	$46K	EMCURE PHARMACEUTICA…
7	ACCORD HEALTHCARE ITALIA SRL	Italy	2	$21K	INTAS PHARMACEUTICAL…	Tablet
8	MR VONMUNA	Laos	1	$7K	KASO PHARMACEUTICALS
9	ALLA FATTURA DELLORDINE EMESSA ALL	Italy	1	$3K	PARKSLEY GLOBAL PVT …	Syrup
10	SALAMA PHARMACUTICALS LTD	Kenya	1	$1K	M T MADON EXPORTS	Tablet
11	CENTRAL POINT PHARMACY	Seychelles	1	$867.97	NALIINI.R.EXPORT PVT…	Tablet
12	THE PURCHASE MANAGER	Chile	1	$585.39	KALINDI OVERSEAS	Tablet
13	CAREWELL PHARMACY (PTY)LTD	Seychelles	2	$409.57	CHEMSELECT PVT LTD	Tablet
14	REPUBLIC OF NAURU, DEPARTMENT OF	Australia	2	$373.08	SYNERGY TRADING	Tablet
15	HEALTH CITY CAYMAN ISLANDS (HCCI)	Cayman Islands	2	$333.37	NARAYANA HRUDAYALAYA…	Tablet
16	LUSAKA PHARMA CHEM SUPPLIES LTD	Zambia	1	$72.88	MEDICOS LIFESCIENCES	Tablet
17	STADA HEMOFARM SRL	Romania	3	$16.33	INTAS PHARMACEUTICAL…	Tablet
18	LLP ROGERS PHARMA	Kazakhstan	1	$0.200	PANACEA BIOTEC PHARM…

This report covers 86 2025-Q4 Mycophenolate shipments. TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020. → transdatanexus.com/pharmaceutical/mycophenolate

Talk to our trade analyst

Need a custom mycophenolate report or a deeper dive into any market? Our team is ready.

WhatsApp: +91 95950 78788 · transdatanexus.com

PHARMA TRADE INTELLIGENCE

Thank you for reading

This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.

Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.

Need a custom report?

We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.

Want deeper analysis?

Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.

Scan for product page

WhatsApp: +91 95950 78788

Email: info@transdatanexus.com

Web: https://transdatanexus.com/pharmaceutical/mycophenolate

© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only. Data sourced from official customs filings and licensed commercial trade databases. Reproduction without permission is prohibited.

Mycophenolate — Export Intelligence Report

Mycophenolate

§2.1 Reporting parameters · the scope of this 2025-Q4 Mycophenolate India trade report

§2.2 Our quality process · Figure 2.1

§2.3 Trust signals · what you can rely on in the numbers you read

§2.4 Limitations · what the data does and does not tell you

§3.1 Monthly summary

§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers

§4.2 Destination concentration

Product variety — how many formulations each supplier ships

§5.1 Supplier concentration metrics

§5.2 Coming next: 3 exporter deep-dive profiles

EMCURE PHARMACEUTICALS LTD

EMCURE PHARMACEUTICALS LTD — Supplier → Country → Importer

SANDOZ PVT LTD

SANDOZ PVT LTD — Supplier → Country → Importer

INTAS PHARMACEUTICALS LTD

INTAS PHARMACEUTICALS LTD — Supplier → Country → Importer

§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?

§6.2 Single-source lock-in by country

§6.3 Price positioning — top 18 importers

§7.1 Price distribution · Table 7.1

§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices

§7.3 Procurement cheat sheet — median USD/unit by country × dosage

§8.1 Reference transit times for key India → global corridors

§9.1 Single-source dependencies

§9.2 Multi-source resilience

§9.3 Sourcing recommendations · Table 9.1

§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers

§10.1 Global totals

§10.2 Regional breakdown

§10.3 Key insights from the data

§10.4 How to read a country page

Top 6 destination countries in Africa

Top 8 Indian suppliers into Africa

Top 4 Africa importers

Top 2 dosage forms

Monthly trend

Shipment register · 10 rows · grouped by exporter

Top 7 destination countries in Asia

Top 6 Indian suppliers into Asia

Top 2 Asia importers

Top 2 dosage forms

Monthly trend

Shipment register · 10 rows · grouped by exporter

Top 7 destination countries in Europe

Top 4 Indian suppliers into Europe

Top 4 Europe importers

Top 4 dosage forms

Monthly trend

Shipment register · 35 rows · grouped by exporter

Top 6 destination countries in Americas

Top 6 Indian suppliers into Americas

Top 6 Americas importers

Top 5 dosage forms

Monthly trend

Shipment register · 23 rows · grouped by exporter

Top 2 destination countries in Oceania

Top 4 Indian suppliers into Oceania

Top 2 Oceania importers

Top 3 dosage forms

Monthly trend

Shipment register · 8 rows · grouped by exporter

Thank you for reading